Giannakakou, Paraskevi
- Weill Cornell Medicine · Internal Medicine (NIH department code)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
FY2019 NIH rank #36,402
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2019Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award categories
- Internal Medicine
NIH Funding · FY2019
Linked Award Amount
$178.8K
Full award amounts, FY2019
Award Records
1
Records listing this PI
Award-Linked Rank
#36,402
By linked amount among FY2019 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2019 award records by amount
NIH award records listing Giannakakou, Paraskevi as a PI. Multi-PI records show the full award amount for context.
- 5R21CA216800-02R21Contact PIBiomarkers of taxane chemotherapy response/resistance in prostate cancerWeill Cornell Medicine · Internal Medicine (NIH department code)$178.8Kaward amount
Award organization
Organizations that administered FY2019 awards listing Giannakakou, Paraskevi as a PI.
FY2019 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardWeill Cornell Medicine
- 2006$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2018$5M Cumulative Funding